Investigating intravascular injection during trigeminal nerve blocks
Incidence of Intravascular (IV) Injection During Trigeminal Nerve Blocks and Impact of Needle Types to the IV Uptake: A Prospective Cohort Study
Seoul National University · NCT04467398
This study is testing if using different types of needles during trigeminal nerve blocks affects how often doctors accidentally inject into a blood vessel in patients with facial pain.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 19 Years to 85 Years |
| Sex | All |
| Sponsor | Seoul National University (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT04467398 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the incidence of intravascular injection that occurs during trigeminal nerve blocks. Patients scheduled for these procedures will be randomized into two groups based on the type of needle used: the tuohy needle group and the quincke needle group. The study will monitor and record any instances of intravascular injection during the nerve block procedures. This research could provide valuable insights into the safety and efficacy of different needle techniques in managing facial pain.
Who should consider this trial
Good fit: Ideal candidates for this study are patients scheduled to undergo trigeminal nerve blocks due to facial pain.
Not a fit: Patients who may not benefit from this study include those who refuse participation, are pregnant, have coagulopathy, have local or systemic infections, have allergies to the injectate, or have anatomical deformations of the skull.
Why it matters
Potential benefit: If successful, this study could enhance the safety of trigeminal nerve block procedures for patients suffering from facial pain.
How similar studies have performed: While this study focuses on a specific aspect of nerve blocks, similar studies have shown varying success in improving procedural safety and outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patients who scheduled to undergo trigeminal nerve block due to the facial pain Exclusion Criteria: * Refusal of the patient * Pregnancy * Coagulopathy * Local or systemic infection * Allergy to injectate * Anatomical deformation of the skull
Where this trial is running
Seoul
- Seoul National University Hospital — Seoul, Korea, Republic of (RECRUITING)
Study contacts
- Study coordinator: Jee Youn Moon, MD, PhD
- Email: jymoon0901@gmail.com
- Phone: 82220722952
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Trigeminal Neuralgia, Facial Pain, Postherpetic Neuralgia, Cluster Headache